4th Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for WALGREEN CO.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Pharmacist provider status Pharmacy benefits on military bases Issues related to drug pricing Issues related to COVID-19 relief H.R. 5376, Inflation Reduction Act of 2022 S.936/H.R. 5502 INFORM Act H.R. 7776, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 H.R. 2617, Consolidated Appropriations Act, 2023

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7776 (117th), H.R. 2617 (117th), S. 936 (117th), H.R. 5502 (117th), H.R. 5376 (117th)

Health Issues HCR

Immunization program COVID-19 testing

LobbyistCovered position, as disclosed
LAKEITHA ANDERSON —
LAURA JOHNSON BOLLIER —
NADEAM ELSHAMI —
BRIAN WILD —
ARI ZIMMERMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Foreign Relations FOR

Foreign relations issues Market access Visa issues

LobbyistCovered position, as disclosed
DOUGLAS MAGUIRE —

Contacted: State, Dept of (DOS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.